Advertisement
Screener

CUBIST PHARMACEUTICALS INC Proceeds from Common Stock Issued

CUBIST PHARMACEUTICALS INC Proceeds from Common Stock Issued

CUBIST PHARMACEUTICALS INC reported Proceeds from Common Stock Issued of $33.06 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2014-11-07

  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2014-09-30 was $12.68M, a 23.98% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2014-06-30 was $3.10M, a 77.59% decline year-over-year.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2014-03-31 was $17.28M, a 209.97% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-12-31 was $9.45M, a 29.35% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2013 was $39.07M, a 8.14% increase from fiscal 2012.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2012 was $36.13M, a 41.31% decline from fiscal 2011.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2011 was $61.55M, a 276.92% increase from fiscal 2010.
  • CUBIST PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2010 was $16.33M, a 244.25% increase from fiscal 2009.
Period endProceeds from Issuance of Common Stock 3 monthProceeds from Issuance of Common Stock 6 monthProceeds from Issuance of Common Stock 9 monthProceeds from Issuance of Common Stock 12 month
2014-09-30$12.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$15.78M
derived: sum of 2 quarters · filed 2014-11-07
$33.06M
10-Q · filed 2014-11-07
$42.50M
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30$3.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$20.37M
10-Q · filed 2014-08-11
$29.82M
derived: sum of 3 quarters · filed 2014-08-11
$40.05M
derived: sum of 4 quarters · filed 2014-11-07
2014-03-31$17.28M
10-Q · filed 2014-05-02
$26.72M
derived: sum of 2 quarters · filed 2014-05-02
$36.95M
derived: sum of 3 quarters · filed 2014-11-07
$50.77M
derived: sum of 4 quarters · filed 2014-11-07
2013-12-31$9.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$19.68M
derived: sum of 2 quarters · filed 2014-11-07
$33.49M
derived: sum of 3 quarters · filed 2014-11-07
$39.07M
10-K · filed 2014-02-25
2013-09-30$10.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$24.05M
derived: sum of 2 quarters · filed 2014-11-07
$29.62M
10-Q · filed 2014-11-07
$36.92M
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30$13.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$19.39M
10-Q · filed 2014-08-11
$26.69M
derived: sum of 3 quarters · filed 2014-08-11
$38.17M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$5.57M
10-Q · filed 2014-05-02
$12.88M
derived: sum of 2 quarters · filed 2014-05-02
$24.35M
derived: sum of 3 quarters · filed 2014-05-02
$29.74M
derived: sum of 4 quarters · filed 2014-05-02
2012-12-31$7.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$18.78M
derived: sum of 2 quarters · filed 2014-02-25
$24.16M
derived: sum of 3 quarters · filed 2014-02-25
$36.13M
10-K · filed 2014-02-25
2012-09-30$11.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$16.86M
derived: sum of 2 quarters · filed 2013-11-12
$28.82M
10-Q · filed 2013-11-12
$54.91M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$5.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$17.35M
10-Q · filed 2013-08-06
$43.44M
derived: sum of 3 quarters · filed 2014-02-25
$53.11M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$11.96M
10-Q · filed 2013-05-07
$38.05M
derived: sum of 2 quarters · filed 2014-02-25
$47.73M
derived: sum of 3 quarters · filed 2014-02-25
$70.75M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$26.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$35.76M
derived: sum of 2 quarters · filed 2014-02-25
$58.78M
derived: sum of 3 quarters · filed 2014-02-25
$61.55M
10-K · filed 2014-02-25
2011-09-30$9.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$32.69M
derived: sum of 2 quarters · filed 2012-11-05
$35.47M
10-Q · filed 2012-11-05
$38.02M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$23.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$25.79M
10-Q · filed 2012-08-07
$28.35M
derived: sum of 3 quarters · filed 2013-02-27
$32.42M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$2.77M
10-Q · filed 2012-05-01
$5.33M
derived: sum of 2 quarters · filed 2013-02-27
$9.40M
derived: sum of 3 quarters · filed 2013-02-27
$16.26M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$2.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$6.62M
derived: sum of 2 quarters · filed 2013-02-27
$13.48M
derived: sum of 3 quarters · filed 2013-02-27
$16.33M
10-K · filed 2013-02-27
2010-09-30$4.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$10.93M
derived: sum of 2 quarters · filed 2011-11-02
$13.78M
10-Q · filed 2011-11-02
$14.06M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-30$6.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29
$9.71M
10-Q · filed 2011-07-29
$9.99M
derived: sum of 3 quarters · filed 2012-02-27
$12.69M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-31$2.85M
10-Q · filed 2011-04-29
$3.13M
derived: sum of 2 quarters · filed 2012-02-27
$5.83M
derived: sum of 3 quarters · filed 2012-02-27
2009-12-31$287.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$2.99M
derived: sum of 2 quarters · filed 2012-02-27
$4.74M
10-K · filed 2012-02-27
2009-09-30$2.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29
$4.46M
10-Q · filed 2010-10-29
2009-06-30$1.76M
10-Q · filed 2010-07-30
2008-12-31$14.42M
10-K · filed 2011-02-23